Pancreatic Cancer Research

ResearcherNational University of SingaporeActive in the last 2 years

Kennedy Yao Yi Ng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6630-3803; OpenAlex author ID A5008209553. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Neoadjuvant therapy versus upfront surgery for resectable pancreatic cancer: Updated systematic review, individual-patient-data meta-analysis and trial sequent… Co-author DOI 10.1016/j.surg.2025.109872↗
  2. Clinical Outcomes of Neoadjuvant Therapy Versus Upfront Surgery in Resectable Pancreatic Cancer: Systematic Review and Meta-analysis of Latest Randomized Contr… Co-author DOI 10.1245/s10434-024-16674-y↗
  3. Resected pancreatic adenocarcinoma: An Asian institution's experience. Co-author DOI 10.1002/cnr2.1393↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ye Xin Koh · 3 shared papers, 2021–2026 · strength 0.65
  2. David Wai-Meng Tai · 3 shared papers, 2021–2026 · strength 0.65
  3. Brian K. P. Goh · 3 shared papers, 2021–2026 · strength 0.65
  4. Hwee Leong Tan · 2 shared papers, 2025–2026 · strength 0.55
  5. Yun Zhao · 2 shared papers, 2025–2026 · strength 0.55
  6. Anna Ho Yin Chan · 1 shared paper, 2025 · strength 0.25
  7. Ser Yee Lee · 1 shared paper, 2021 · strength 0.10
  8. Pierce K. H. Chow · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.